Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma

Aim: To analyze antitumor efficacy of experimental cancer vaccine therapy combined with introduction of vitamin D3 (VD3) for treatment of Lewis lung carcinoma (3LL). Materials and Methods: Cancer vaccines composed from recombinant murine beta-defensin-2 (mBD-2) and 3LL cell lysate, or DNA, coding fo...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2010
Автори: Zhuravel, E., Efanova, O., Shestakova, T., Glushko, N., Mezhuev, O., Soldatkina, M., Pogrebnoy, P.V.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2010
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/138597
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma / E. Zhuravel, O. Efanova, T. Shestakova, N. Glushko, O. Mezhuev, M. Soldatkina, P.V. Pogrebnoy // Experimental Oncology. — 2010. — Т. 32, № 1. — С. 33-39. — Бібліогр.: 37 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-138597
record_format dspace
spelling irk-123456789-1385972018-06-20T03:05:25Z Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma Zhuravel, E. Efanova, O. Shestakova, T. Glushko, N. Mezhuev, O. Soldatkina, M. Pogrebnoy, P.V. Original contributions Aim: To analyze antitumor efficacy of experimental cancer vaccine therapy combined with introduction of vitamin D3 (VD3) for treatment of Lewis lung carcinoma (3LL). Materials and Methods: Cancer vaccines composed from recombinant murine beta-defensin-2 (mBD-2) and 3LL cell lysate, or DNA, coding for mBD-2-Muc1 fusion construct cloned in pcDNA3+ vector, were prepared and used for intradermal vaccination. Experimental cancer vaccines introduced i. d. at therapeutic and prophylactic regimens to 3LLbearing C57Bl mice, were applied alone or in combination with VD3 (administered per os) and/or low-dose cyclophosphamide (CP, administered intraperitoneal). Efficacy of treatments was analyzed by primary tumor growth dynamics indexes and by metastasis rate in vaccinated animals. Results: As it has been shown, administration of the protein-based vaccine composed from mBD-2 and 3LL cell lysate in combination with VD3 and CP, but not in VD3 free setting, led to significant suppression of primary tumor growth (p < 0.005) and had significant antimetastatic effect. Introduction of VD3 with or without CP in the scheme of treatment with mBD-2-Muc1-DNA vaccine at therapeutic regimen has led to significant suppression of primary tumor (p < 0.05) and metastasis volumes (p < 0.005), while in the groups of animals treated with DNA-vaccine + VD3 with or without CP at prophylactic regimen, significant antimetastatic effect (p < 0.05) and elevation of average life-span (p < 0.05) have been registered. Conclusion: The results of this pilot study have shown promising clinical effects of VD3 administration in combination with cancer vaccinotherapy in vivo. 2010 Article Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma / E. Zhuravel, O. Efanova, T. Shestakova, N. Glushko, O. Mezhuev, M. Soldatkina, P.V. Pogrebnoy // Experimental Oncology. — 2010. — Т. 32, № 1. — С. 33-39. — Бібліогр.: 37 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138597 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Zhuravel, E.
Efanova, O.
Shestakova, T.
Glushko, N.
Mezhuev, O.
Soldatkina, M.
Pogrebnoy, P.V.
Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
Experimental Oncology
description Aim: To analyze antitumor efficacy of experimental cancer vaccine therapy combined with introduction of vitamin D3 (VD3) for treatment of Lewis lung carcinoma (3LL). Materials and Methods: Cancer vaccines composed from recombinant murine beta-defensin-2 (mBD-2) and 3LL cell lysate, or DNA, coding for mBD-2-Muc1 fusion construct cloned in pcDNA3+ vector, were prepared and used for intradermal vaccination. Experimental cancer vaccines introduced i. d. at therapeutic and prophylactic regimens to 3LLbearing C57Bl mice, were applied alone or in combination with VD3 (administered per os) and/or low-dose cyclophosphamide (CP, administered intraperitoneal). Efficacy of treatments was analyzed by primary tumor growth dynamics indexes and by metastasis rate in vaccinated animals. Results: As it has been shown, administration of the protein-based vaccine composed from mBD-2 and 3LL cell lysate in combination with VD3 and CP, but not in VD3 free setting, led to significant suppression of primary tumor growth (p < 0.005) and had significant antimetastatic effect. Introduction of VD3 with or without CP in the scheme of treatment with mBD-2-Muc1-DNA vaccine at therapeutic regimen has led to significant suppression of primary tumor (p < 0.05) and metastasis volumes (p < 0.005), while in the groups of animals treated with DNA-vaccine + VD3 with or without CP at prophylactic regimen, significant antimetastatic effect (p < 0.05) and elevation of average life-span (p < 0.05) have been registered. Conclusion: The results of this pilot study have shown promising clinical effects of VD3 administration in combination with cancer vaccinotherapy in vivo.
format Article
author Zhuravel, E.
Efanova, O.
Shestakova, T.
Glushko, N.
Mezhuev, O.
Soldatkina, M.
Pogrebnoy, P.V.
author_facet Zhuravel, E.
Efanova, O.
Shestakova, T.
Glushko, N.
Mezhuev, O.
Soldatkina, M.
Pogrebnoy, P.V.
author_sort Zhuravel, E.
title Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
title_short Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
title_full Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
title_fullStr Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
title_full_unstemmed Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
title_sort administration of vitamin d3 improves antimetastatic efficacy of cancer vaccine therapy of lewis lung carcinoma
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2010
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/138597
citation_txt Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma / E. Zhuravel, O. Efanova, T. Shestakova, N. Glushko, O. Mezhuev, M. Soldatkina, P.V. Pogrebnoy // Experimental Oncology. — 2010. — Т. 32, № 1. — С. 33-39. — Бібліогр.: 37 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT zhuravele administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT efanovao administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT shestakovat administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT glushkon administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT mezhuevo administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT soldatkinam administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
AT pogrebnoypv administrationofvitamind3improvesantimetastaticefficacyofcancervaccinetherapyoflewislungcarcinoma
first_indexed 2023-10-18T21:18:07Z
last_indexed 2023-10-18T21:18:07Z
_version_ 1796152450504196096